Scarica l'app Stockscreener
237.27
2.46%
5.69
Dopo l'orario di chiusura:
233.23
-4.04
-1.70%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$231.58
Aprire:
$231
Volume 24 ore:
2.32M
Relative Volume:
2.61
Capitalizzazione di mercato:
$34.83B
Reddito:
$4.81B
Utile/perdita netta:
$1.11B
Rapporto P/E:
38.52
EPS:
6.16
Flusso di cassa netto:
$1.35B
1 W Prestazione:
-0.52%
1M Prestazione:
-1.77%
6M Prestazione:
+11.25%
1 anno Prestazione:
+36.39%
Intervallo 1D:
$231.00
$238.60
Intervallo di 1 settimana:
$229.94
$245.19
Portata 52W:
$164.12
$260.49
Resmed Inc Stock (RMD) Company Profile
Nome
Resmed Inc
Settore
Industria
Telefono
(858) 746-2400
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Confronta RMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
237.27 | 34.83B | 4.81B | 1.11B | 1.35B | 7.55 |
|
ISRG
Intuitive Surgical Inc
|
524.43 | 186.79B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
227.68 | 65.83B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.76 | 41.92B | 9.76B | 1.16B | 665.00M | 2.34 |
|
WST
West Pharmaceutical Services Inc
|
331.40 | 24.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-13 | Iniziato | Stifel | Hold |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-09-18 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | Downgrade | Needham | Buy → Hold |
| 2024-06-25 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-06-24 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | Aggiornamento | Needham | Hold → Buy |
| 2023-09-05 | Downgrade | UBS | Buy → Neutral |
| 2023-08-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | Iniziato | UBS | Buy |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-01-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-09-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-08-15 | Downgrade | CLSA | Buy → Outperform |
| 2022-08-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-08-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-01-28 | Aggiornamento | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-01-13 | Aggiornamento | CLSA | Outperform → Buy |
| 2022-01-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-10-22 | Aggiornamento | CLSA | Underperform → Outperform |
| 2021-08-02 | Downgrade | CLSA | Outperform → Sell |
| 2021-08-02 | Downgrade | Needham | Buy → Hold |
| 2021-07-28 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-14 | Iniziato | RBC Capital Mkts | Underperform |
| 2021-06-28 | Downgrade | Citigroup | Buy → Neutral |
| 2021-06-22 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-06-22 | Iniziato | Robert W. Baird | Neutral |
| 2021-06-21 | Reiterato | Needham | Buy |
| 2021-06-16 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-06-09 | Aggiornamento | CLSA | Sell → Outperform |
| 2021-05-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-30 | Downgrade | Citigroup | Buy → Neutral |
| 2021-03-16 | Aggiornamento | Needham | Hold → Buy |
| 2020-11-02 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-10-27 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2020-08-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-01 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Iniziato | CLSA | Underperform |
| 2020-01-31 | Downgrade | UBS | Buy → Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Perform |
| 2019-11-22 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | Aggiornamento | UBS | Neutral → Buy |
| 2019-07-16 | Downgrade | UBS | Buy → Neutral |
| 2019-05-06 | Aggiornamento | UBS | Neutral → Buy |
| 2019-04-18 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-01-25 | Downgrade | Goldman | Buy → Neutral |
| 2019-01-25 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | Iniziato | Goldman | Buy |
Mostra tutto
Resmed Inc Borsa (RMD) Ultime notizie
Y Intercept Hong Kong Ltd Reduces Position in ResMed Inc. (NYSE:RMD) - MarketBeat
$18.97 Bn Mechanical Ventilator Market Opportunities and - GlobeNewswire
ResMed Inc.'s (NYSE:RMD) institutional investors lost 4.5% last week but have benefitted from longer-term gains - Simply Wall St
ResMed Inc. stock rises Thursday, outperforms market - MarketWatch
ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch
YieldBoost ResMed From 0.9% To 6.8% Using Options - Nasdaq
ResMed Inc Director Expands Stock Holdings - MSN
XTX Topco Ltd Has $301,000 Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
With 74% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns - Yahoo Finance
Franklin Resources Inc. Increases Stock Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
2,216 Shares in ResMed Inc. (NYSE:RMD) Acquired by World Investment Advisors LLC - MarketBeat
ResMed's SWOT analysis: sleep tech giant faces GLP-1 threat, AI opportunity - Investing.com
ResMed Inc. stock rises Tuesday, outperforms market - MarketWatch
2 ASX companies with the traits of a long-term winner - Morningstar.com.au
Is ResMed Stock Outperforming the Nasdaq? - Nasdaq
Is ResMed Stock Outperforming The Nasdaq? - Barchart
ResMed Inc. stock rises Monday, outperforms market - MarketWatch
Assistive Technology Market Is Booming Worldwide 2024-2031: Dynavox Systems LLC., Invacare Corporation, ResMed - EIN News
Weight-loss drugs draw Americans back to the doctor - Marketscreener.com
The Global Medical Cannula Market Is Poised for Significant Growth USD 447.0 Million by 2034 at a 6.9% of CAGR, driven by Rising Demand for Medical Procedures and Advanced Healthcare Solutions | FMI - GlobeNewswire Inc.
What is William Blair's Estimate for ResMed Q2 Earnings? - MarketBeat
Stifel Initiates Coverage of ResMed Inc.Depositary Receipt () (RSMDF) with Hold Recommendation - MSN
Wellington Management Group LLP Purchases 15,772 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Receives $227.91 Average PT from Brokerages - MarketBeat
Toronto Dominion Bank Has $12.02 Million Stock Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
American Trust Makes New $690,000 Investment in ResMed Inc. (NYSE:RMD) - MarketBeat
Virtu Financial LLC Decreases Stake in ResMed Inc. (NYSE:RMD) - MarketBeat
We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease - Yahoo Finance
ResMed Inc. stock falls Friday, underperforms market - MarketWatch
Why ResMed (RMD) is a Top Value Stock for the Long-Term - Yahoo Finance
ResMed (NYSE:RMD) Now Covered by Analysts at Stifel Nicolaus - MarketBeat
ResMed, The Company Behind Making Sleep Apnea Machines, has Developed The $120 Kontor Head Strap For The Apple Vision Pro To Alleviate Head Strain - Wccftech
Zacks.com featured highlights include InterDigital, ResMed, Greenbrier Companies, Charles River Associates and Kontoor Brands - Yahoo Finance
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
Geode Capital Management LLC Acquires 380,383 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Purchased by Nomura Asset Management Co. Ltd. - MarketBeat
ResMed Inc. stock rises Wednesday, still underperforms market - MarketWatch
ResMed Inc (RMD) CFO Brett Sandercock Sells 1,000 Shares - GuruFocus.com
ResMed CFO Sandercock sells $244,230 in stock By Investing.com - Investing.com South Africa
ResMed CFO Sandercock sells $244,230 in stock - Investing.com
ResMed's SWOT analysis: sleep tech giant faces GLP-1 drug challenge - Investing.com
Stifel Financial Corp Has $14 Million Stock Position in ResMed Inc. (NYSE:RMD) - MarketBeat
National Bank of Canada FI Acquires 19,120 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
'Huge opportunity' ahead for this ASX 200 healthcare stock - MSN
13,712 Shares in ResMed Inc. (NYSE:RMD) Bought by Executive Wealth Management LLC - MarketBeat
iA Global Asset Management Inc. Has $1.40 Million Stock Position in ResMed Inc. (NYSE:RMD) - MarketBeat
What is Zacks Research's Forecast for ResMed Q2 Earnings? - MarketBeat
William Blair Brokers Boost Earnings Estimates for ResMed - MarketBeat
Returns on Capital Paint A Bright Future For ResMed (NYSE:RMD) - Yahoo Finance
Insiders At ResMed Sold US$17m In Stock, Alluding To Potential Weakness - Simply Wall St
Quantinno Capital Management LP Has $6.02 Million Stake in ResMed Inc. (NYSE:RMD) - MarketBeat
Resmed Inc Azioni (RMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.69%
1.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):